Global Dementia Care Shifts to Profit‑Driven Model, Exposing Gaps in Public Funding, Equity, and Indigenous Care Practices
Original framing: “Opinion: STAT+: Dementia finally has a business model” — STAT News
Scientific advances have accelerated biomarker discovery, drug trials, and digital monitoring tools, creating a lucrative pipeline that fuels the business narrative. Yet, the evidence base for many disease‑modifying therapies remains weak, and the emphasis on pharmacology diverts resources from preventive public health measures such as vascular risk management. A balanced scientific agenda would integrate basic research with community‑level interventions.
The emergence of a dementia business model reflects a historic shift toward privatized care that masks deep structural neglect, especially for marginalized and Indigenous populations.
Scientific advances, while promising, are entangled with profit motives that divert attention from preventive public health and culturally resonant caregiving. Cross‑cultural evidence demonstrates that community‑based, relational approaches can sustain dignity and reduce institutional burdens, yet they remain underfunded and invisible in policy. By coupling equitable pricing regulations, publicly funded care networks, and the integration of Indigenous knowledge, societies can transform the current profit‑centric paradigm into a resilient, inclusive system that anticipates demographic growth and honors the lived realities of all stakeholders.